Laurent David

Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships.

Bo Nordén, Klaus Urbahns, B. Springthorpe, 2008, Journal of medicinal chemistry.

The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function.

S. Poda, F. Loechel, C. Volbracht, 2014, Bioorganic & medicinal chemistry letters.